Cerivastatin

Cerivastatin, also known as Baycol, was a medication used to lower cholesterol levels in the body. It belonged to a class of drugs called statins, which work by blocking an enzyme that helps produce cholesterol in the liver. However, Cerivastatin was withdrawn from the market in 2001 due to an increased risk of severe muscle damage, known as rhabdomyolysis, which in some cases could lead to kidney failure and death. Despite its initial effectiveness in lowering cholesterol levels, the potential risks associated with Cerivastatin outweighed its benefits, leading to its removal from the market.